We observed that PRDX2 expression was increased in tumor tissues of 6 out of 9 patients, with the highest expression in HCC cells and peritumoral cholangiocytes (Figure 1F and Supplemental Figure 2A). The gene discussed is PRDX2; the disease is hepatocellular carcinoma.